Page last updated: 2024-11-04

sobuzoxane and ATLL

sobuzoxane has been researched along with ATLL in 4 studies

sobuzoxane: used in treatment of leukemia L1210

Research Excerpts

ExcerptRelevanceReference
"Among 13 acute-type ATLL, one CR and five PR were obtained."2.67Treatment of adult T-cell leukemia/lymphoma with MST-16, a new oral antitumor drug and a derivative of bis(2,6-dioxopiperazine). The MST-16 Study Group. ( Hanada, S; Hirano, M; Masaoka, T; Mitomo, Y; Nagai, K; Ohno, R; Sakamoto, S; Shirakawa, S; Yasunaga, K; Yokomaku, S, 1993)
"Adult T cell leukemia/lymphoma (ATLL) induced by human T cell leukemia virus I is resistant to conventional therapy."2.67Effective treatment of adult T cell leukemia/lymphoma with a novel oral antitumor agent, MST-16. ( Fukutani, H; Ichihashi, T; Kiyoi, H; Kubo, K; Naoe, T; Ohno, R; Yamada, K; Yamauchi, T, 1992)
"Sobuzoxane has an effect to protect against doxorubicin cardiotoxicity."2.40[Oral antitumor drugs for hematological malignancies]. ( Ohnishi, K, 1999)
"The reason why CHOP-resistant ATLL responded dramatically to SBZ alone is not clear, but the plasma concentration of the metabolite of SBZ was possibly very high because of renal failure."1.36[Adult T-cell leukemia/lymphoma in a patient on hemodialysis-resistance to CHOP, but unexpected effect and remission achieved by sobuzoxane alone]. ( Murotani, N; Sakai, C, 2010)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sakai, C1
Murotani, N1
Ohno, R2
Masaoka, T1
Shirakawa, S1
Sakamoto, S1
Hirano, M1
Hanada, S1
Yasunaga, K1
Yokomaku, S1
Mitomo, Y1
Nagai, K1
Ohnishi, K1
Ichihashi, T1
Kiyoi, H1
Fukutani, H1
Kubo, K1
Yamauchi, T1
Naoe, T1
Yamada, K1

Reviews

1 review available for sobuzoxane and ATLL

ArticleYear
[Oral antitumor drugs for hematological malignancies].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:3

    Topics: Administration, Oral; Antineoplastic Agents; Cytarabine; Etoposide; Hematologic Neoplasms; Humans; H

1999

Trials

2 trials available for sobuzoxane and ATLL

ArticleYear
Treatment of adult T-cell leukemia/lymphoma with MST-16, a new oral antitumor drug and a derivative of bis(2,6-dioxopiperazine). The MST-16 Study Group.
    Cancer, 1993, Apr-01, Volume: 71, Issue:7

    Topics: Administration, Oral; Adult; Aged; Animals; Antineoplastic Agents; Cats; Female; Humans; Leukemia-Ly

1993
Effective treatment of adult T cell leukemia/lymphoma with a novel oral antitumor agent, MST-16.
    Oncology, 1992, Volume: 49, Issue:5

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Drug Evaluation; Female; Humans; Leukemia-

1992

Other Studies

1 other study available for sobuzoxane and ATLL

ArticleYear
[Adult T-cell leukemia/lymphoma in a patient on hemodialysis-resistance to CHOP, but unexpected effect and remission achieved by sobuzoxane alone].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Resistance

2010
chemdatabank.com